Inorg. Chem. 1998, 37, 6125-6128
6125
As a further study into the various binding modes of orotic
acid derivatives with metals, we describe in this communication
the synthesis of a bis(triphenylphosphine)copper(I) orotate
complex, as well as a bis(triphenylphosphine)copper(I) dihy-
droorotate complex and examine their crystal structures. These
compounds are the first examples of orotic acid derivatives of
copper in the +1 oxidation state. Copper(I) is isoelectronic with
the biologically more relevant zinc(II) species, and this study
provides the first structural data of complexes containing the
same d10 metal fragment bound separately to the orotate and
dihydroorotate ligands.
Bis(triphenylphosphine)copper(I) Complexes of
Orotate and L-Dihydroorotate
Donald J. Darensbourg,* David L. Larkins, and
Joseph H. Reibenspies
Department of Chemistry, Texas A&M University,
P.O. Box 30012, College Station, Texas 77842
ReceiVed April 23, 1998
Introduction
Orotic acid derivatives and their complexes with metal ions
have recently been investigated by several research groups.1 The
importance of orotic acid as a metal ion carrier and as a
precursor in the biosynthesis of the pyrimidine nucleotides of
DNA has spawned this interest. The pathway of the biosyn-
thesis of thymidine and cytosine proceeds through the function
of several enzymes that have active sites containing various
metal ions. For instance, the enzyme dihydroorotase which
cyclizes the N-carbamyl-L-aspartase unit to form dihydroorotic
acid has an active site containing Zn,2 and investigations of the
binding of Zn to dihydroorotic acid have recently been published
by two research groups.3,4 Another example of an enzyme along
the biosynthetic pathway of orotic acid that contains a metal at
Experimental Section
Materials and Methods. All manipulations were performed on a
double-manifold Schlenk vacuum line under an atmosphere of argon
or in an argon-filled glovebox. All of the solvents used were dried
and deoxygenated by distillation from the appropriate reagent under a
nitrogen atmosphere. Infrared spectra were collected on a Matteson
6022 spectrometer with DTGS and MCT detectors in a 0.10-mm CaF2
cell. Copper(I) acetate and copper(I) bis(triphenylphosphine) acetate
were prepared according to previously reported methods.9 Orotic acid
monohydrate was purchased from Aldrich Chemical and used without
further purification. Triphenylphosphine was purchased from Lancaster
Synthesis, Inc., and used without further purification. L-Dihydroorotic
acid was purchased from Sigma Chemical and used as received.
Microanalyses were performed by Canadian Microanalytical Service,
Ltd. (Delta, B.C., Canada).
Synthesis of Cu(I) Bis(triphenylphosphine) Orotate, 1. The
synthesis of 1 was accomplished in yields in excess of 80% by the
reaction of 1 equiv of Cu(I) bis(triphenylphosphine) acetate with 1 equiv
of the orotic acid monohydrate in a 1:1 THF/methanol mixture. This
affords a greenish-yellow solution from which the solvent is removed,
leaving behind a pale greenish-yellow powder. Crystals of 1 were
obtained via slow diffusion of diethyl ether into the THF/methanol
the active site is that of dihydroorotate dehydrogenase.
A
recently obtained crystal structure of this enzyme by Nielsen
and co-workers has shown that this enzyme contains an iron-
sulfur cluster as a cofactor.5 In addition to the importance of
metal complexes of orotic acid derivatives in the biosynthesis
of pyrimidine nucleotides, some other metal complexes have
been found to show significant anticancer activity.6 Alternative
studies reported from our laboratories have examined the binding
of orotate and dihydroorotate derivatives in organometallic
derivatives, namely, group 6 metal carbonyls.7 These studies
have demonstrated that the chelated, deprotonated nitrogen of
the uracil ring can exhibit significant π-donating capability and
thus greatly enhance CO lability in these metal carbonyl
complexes.8 Yet, despite the obvious importance of metal
complexes of orotic acid and its derivatives, their coordination
chemistry heretofore has been relatively underexplored.
solution of
1 at -10 °C. Anal. Calcd for Cu(PC18H15)2-
(C5H3N2O4)‚MeOH [C42H37P2N2O5Cu]: C, 65.07; H, 4.81; N, 3.61.
Found: C, 64.67; H, 4.82; N, 3.62.
Synthesis of Cu(I) Bis(triphenylphosphine) Dihydroorotate, 2.
The synthesis of 2 was accomplished in yields in excess of 80% by
the reaction of 1 equiv of Cu(I) bis(triphenylphosphine) acetate with 1
equiv of L-dihydroorotic acid in 30 mL of methanol. The resulting
product is a clear, nearly colorless solution from which the solvent is
removed, leaving behind an off-white powder. Crystals of 2 were
obtained by concentrating the reaction solution to 5 mL and refrigerating
at 10 °C overnight. Anal. Calcd. for Cu(PC18H15)2(C5H5N2O4)‚MeOH
[C42H39P2N2O5Cu]: C, 64.90; H, 5.06; N, 3.60. Found: C, 64.37; H,
4.99; N, 3.64.
X-ray Crystallography of 1 and 2. Cu(PPh3)2(orotate), 1. Crystal
data and the details of data collection for 1 are given in Table 1. A
pale green block of 1 was mounted on glass fibers with epoxy cement
at room temperature and then cooled in a liquid-nitrogen cold stream.
X-ray diffraction data were collected on a Rigaku AFC5R X-ray
diffractometer (Cu KR, λ ) 1.541 78 Å radiation). Cell parameters
were calculated from the least-squares fitting of the setting angles for
24 reflections. Data were collected for 3.58° < θ < 50.00°. Three
control reflections, collected for every 97 reflections, showed no
significant trends. Lorentz and polarization corrections were applied
to 1895 reflections, and a total of 1766 unique reflections were used
in further calculations. The structure was solved by direct methods
[SHELXS program package, Sheldrick (1993)], and an empirical
absorption correction was applied (difabs). Full-matrix least-squares
anisotropic refinement for all non-hydrogen atoms yielded R ) 0.0956,
Rw ) 0.2090, and S ) 0.980 for 1. Hydrogen atoms were placed in
(1) Mutikainen, I. Ann. Acad. Sci. Fen. Ser. A. Chem. Soc.; 1988, 7. (b)
Burrows, A. D.; Mingos, M. P.; White, A. J. P.; Williams, D. J. J.
Chem. Soc.; Dalton Trans. 1996, 149. (c) Nepveu, F.; Gaultier, N.;
Korber, N.; Jaud, J.; Castan, P. J. Chem. Soc., Dalton Trans. 1995,
4005. (d) Kumberger, O.; Riede, J.; Schmidbaur, H. Chem. Ber. 1991,
124, 2739. (e) Bach, I.; Kumberger, O.; Schmidbaur, H. Chem. Ber.
1990, 123, 2267. (f) Castan, P.; Ha, T.; Nepveu, F.; Bernardinelli, G.
Inorg. Chim. Acta 1994, 221, 173.
(2) Lehninger, A. L.; Nelson, D. L.; Cox, M. M. Principles of Biochem-
istry; Worth Publishers: New York, 1993; p 721. (b) Christopherson,
R. I.; Lyons, S. D. Med. Res. ReV. 1990, 10, 505. (c) Kelly, R. E.;
Mally, M. I.; Evans, D. R. J. Biol. Chem. 1986, 261, 6073.
(3) Hambley, T. W.; Christopherson, R. I.; Zvargulis, E. S. Inorg. Chem.
1995, 34, 6550.
(4) Ruf, M.; Weis, K.; Vahrenkamp, H. Inorg. Chem. 1997, 36, 2130.
(5) Nielsen, F. S.; Anderson, P. S.; Jensen, K. F. J. Biol. Chem. 1996,
271, 29359. (b) Rowland, P.; Nielsen, F. S.; Jensen, K. F.; Larsen, S.
Acta Crystallogr., Sect. D 1997, 53, 802.
(6) Castan, P.; Colacio-Rodriguez, E.; Beauchamp, A. L.; Cros, S.;
Wimmer, J. J. Inorg. Biochem. 1990, 38, 225.
(7) Darensbourg, D. J.; Draper, J. D.; Larkins, D. L.; Frost, B. J.;
Reibenspies, J. H. Inorg. Chem. 1998, 37, 2538.
(8) Poulton, J. T.; Folting, K.; Streib, W. E.; Caulton, K. G. Inorg. Chem.
1992, 31, 3190. (b) Poulton, J. T.; Sigalas, M. P.; Folting, K.; Streib,
W. E.; Einstein, O.; Caulton, K. G. Inorg. Chem. 1994, 33, 1476. (c)
Brown, T. L.; Atwood, J. D. J. Am. Chem. Soc. 1976, 98, 3160. (d)
Lichtenberger, D. L.; Brown, T. L. J. Am. Chem. Soc. 1978, 100, 366.
(9) Darensbourg, D. J.; Holtcamp, M. W.; Longridge, E. M.; Klausmeyer,
K. K.; Reibenspies, J. H. Inorg. Chim. Acta 1994, 227, 223.
10.1021/ic980464m CCC: $15.00 © 1998 American Chemical Society
Published on Web 10/24/1998